CSIMarket


Charles River Laboratories International inc   (CRL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Charles River Laboratories International inc

CRL's Fundamental analysis








Charles River Laboratories International Inc 's sales fell by -1.73 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1046

Medical Laboratories industry recorded growth of revenues by 2.66 %

Charles River Laboratories International Inc 's net profit deacreased by -28.35 % in I. Quarter 2024 year on year, to $74 millions.

More on CRL's Growth


Charles River Laboratories International Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Company is currently trading with Price to Cash flow multiple of 88.32 in trailing twelve-month period.
Company
25.97
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.78.
Medical Laboratories industry's Price to Sales ratio is at 3.16.


More on CRL's Valuation
 
 Total Debt (Millions $) 2,660
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 205,580
 Net Income/Employee (TTM) $ 22,545
 Receivable Turnover (TTM) 5.19
 Tangible Book Value (Per Share $) -4.86

Charles River Laboratories International Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Company is currently trading with Price to Cash flow multiple of 88.32 in trailing twelve-month period.
Company
25.97
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.78.
Medical Laboratories industry's Price to Sales ratio is at 3.16.

Charles River Laboratories International Inc Price to Book Ratio is at 3.14 lower than Indusry Avg. of 426.22. and higher than S&P 500 Avg. of 0.01

More on CRL's Valuation

  Market Capitalization (Millions $) 11,450
  Shares Outstanding (Millions) 52
  Employees 20,000
  Revenues (TTM) (Millions $) 4,112
  Net Income (TTM) (Millions $) 451
  Cash Flow (TTM) (Millions $) 130
  Capital Exp. (TTM) (Millions $) -291
  Total Debt (Millions $) 2,660
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 205,580
  Net Income/Employee(TTM) $ 22,545
  Receivable Turnover Ratio (TTM) 5.19
  Tangible Book Value (Per Share $) -4.86

  Market Capitalization (Millions $) 11,450
  Shares Outstanding (Millions) 52
  Employees 20,000
  Revenues (TTM) (Millions $) 4,112
  Net Income (TTM) (Millions $) 451
  Cash Flow (TTM) (Millions $) 130
  Capital Exp. (TTM) (Millions $) -291


    CRL's Profitability Comparisons
Charles River Laboratories International Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 12.45 % from 13.12 % in IV. Quarter.

Charles River Laboratories International Inc net profit margin of 7.36 % is currently ranking no. 8 in Medical Laboratories industry, ranking no. 85 in Healthcare sector and number 1164 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 2.39
  Total Debt to Equity (MRQ) 0.73
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.52
  Inventory Turnover Ratio (TTM) 7.27



Charles River Laboratories International Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 12.45 % from 13.12 % in IV. Quarter.

Charles River Laboratories International Inc net profit margin of 7.36 % is currently ranking no. 8 in Medical Laboratories industry, ranking no. 85 in Healthcare sector and number 1164 in S&P 500.

More on CRL's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com